At the Jill Roberts Center for Inflammatory Bowel Disease (JRC), our mission is to prevent and cure Crohn’s disease and colitis while caring for our patients. Our comprehensive, coordinated clinical program is dedicated to improving the quality of life for people with IBD, a condition affecting more than 2 million Americans.
The JRC was founded in 2006 by world-renowned IBD expert Ellen J. Scherl, M.D., as a multidisciplinary center of excellence with the mission of caring for patients while searching for an IBD cure. Under the direction of Dr. Scherl, the JRC has grown into one of the nation’s leading multidisciplinary centers for the diagnosis, comprehensive care and innovative treatment of patients with Crohn’s disease and ulcerative colitis. JRC patients have access to the latest advancements in IBD diagnosis and treatment across disciplines through the Weill Cornell Medicine/NewYork-Presbyterian Hospital family of healthcare professionals.
JRC has developed a robust translational research program that aims to elucidate the mechanisms of immune- and molecular-mediated gastrointestinal inflammation in IBD. Physicians at JRC collaborate with researchers at the Jill Roberts Institute for Research in Inflammatory Bowel Disease, where work is being done to translate basic research breakthroughs into the most advanced therapies for patients with IBD. Patients at JRC have the opportunity to participate in cutting edge clinical trials, while receiving care from JRC physicians who are at the top of their field.
JRC is proud to be a part of NewYork-Presbyterian Hospital, Weill Cornell Medical Center and the Weill Cornell Medical College Joan and Sanford I. Weill Department of Medicine Division of Gastroenterology and Hepatology.